TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,499,412 | +238.8% | 3,635,281 | +482.0% | 0.02% | +220.0% |
| Q2 2023 | $9,593,902 | +37841.6% | 624,603 | -44.4% | 0.01% | -64.3% |
| Q1 2023 | $25,286 | +39.6% | 1,124,338 | +30.6% | 0.01% | +40.0% |
| Q4 2022 | $18,108 | -99.9% | 861,045 | +23.2% | 0.01% | 0.0% |
| Q3 2022 | $17,223,000 | +268.6% | 698,999 | +262.5% | 0.01% | +233.3% |
| Q2 2022 | $4,672,000 | -78.5% | 192,816 | -77.1% | 0.00% | -75.0% |
| Q1 2022 | $21,740,000 | +141.3% | 843,629 | +190.6% | 0.01% | +140.0% |
| Q4 2021 | $9,011,000 | +126.6% | 290,303 | +77.1% | 0.01% | +150.0% |
| Q3 2021 | $3,976,000 | +932.7% | 163,948 | +521.7% | 0.00% | – |
| Q2 2021 | $385,000 | -96.5% | 26,371 | -93.9% | 0.00% | -100.0% |
| Q1 2021 | $10,879,000 | -45.1% | 435,682 | -40.1% | 0.01% | -42.9% |
| Q4 2020 | $19,819,000 | – | 727,176 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |